Metabolic profile and sex hormone binding globulin (SHBG) in different reproductive phases of Czech women and their relations to weight, body composition and fat distribution

Physiological Research

Volumn 58, Issue 3, 2009, Pages 393-402

  Koskova I ^a   Petrasek R ^b   Vondra, K ^c   Duskova M ^c   Starka L ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Central adiposity; Lipid profile; Menopause; SHBG

Indexed keywords

BIOLOGICAL MARKER; INSULIN; LIPID; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY WEIGHT; COMPARATIVE STUDY; CZECH REPUBLIC; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; MENOPAUSE; METABOLISM; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; TIME;

ADIPOSITY; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; CONTRACEPTIVES, ORAL; CZECH REPUBLIC; ENERGY METABOLISM; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN; LIPIDS; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TIME FACTORS; YOUNG ADULT;

EID: 68649123093     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabet Med 5: 469-480, 2006.
2. Bláha P, Šedivý V, Čechovský K, Kosová A: Anthropometric studies of the Czechoslovak population from 6 to 55 years, Czechoslovak Spartakiade 1985, vol. 1, part 2, Ústřední štáb československé spartakiády, Prague, 1986, pp 139-262.
3. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzel JD, Shofer JB, Fish BE, Knopp RH, Kahn SE: Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 538: 2087-2094, 2004.
4. Clearfield M: Coronary heart disease risk reduction in postmenopausal women: the role of statin therapy and hormone replacement therapy. Prev Cardiol 7: 131-136, 2004.
5. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DB, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51: 1005-1015, 2002.
6. Gilliat-Wimberly M, Manore MM, Woolf K, Swan PD, Carroll SS: Effects of habitual physical activity on the resting metabolic rates and body compositions of women aged 35 to 50 years. J Am Diet Assoc 101: 1181-1188, 2001.
7. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan B, Dobs A: Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160: 540-548, 2004.
8. Gower BA, Nagy TR, Goran MI, Toth MJ, Poehlman ET: Fat distribution and plasma lipid-lipoprotein concentrations in pre- and postmenopausal women. Int J Obes Relat Metab Disord 22: 605-611, 1998.
9. Haffner SM, Dunn JF, Katz MS: Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 41: 278-284, 1992.
10. Hainer V, Kunešová M, Pařízková J, Mikulová R, Stunkard A: Serum cortisol and sex hormone binding globulin (SHBG) levels, body fat distribution and the role of genetic factors in obese females. Sb Lek 4: 471-475, 2002.
11. Kazmarová H, Kodl M: Risk factors for noncommunicable diseases in the population of the Czech Republic in the relationship to intervention programmes (in Czech), www.szu.cz/czzp/cindi/vrf.html, 2001, accessed 06-03-2007.
12. Kosková I, Petrásek R, Vondra K, Bláha P, Skibová J, Glagoličová A, Karasová L: Weight, body composition and fat distribution of Czech women in relation with reproductive phase: a cross-sectional study. Prague Med Rep 108: 13-26, 2007a.
13. Kosková I, Petrásek R, Vondra K, Skibová J: Weight, body composition and fat distribution changes of Czech women in the different reproductive phases: a longitudinal study. Prague Med Rep 108: 226-242, 2007b.
14. Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111: 383-390, 1986.
15. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjostrom L: Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes 13: 413-423, 1989.
16. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF: Changes in cardiovascular risk factors during perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 32: 1104-1111, 2001.
17. Owens JF, Matthews KA, Wing RR, Kuller LH: Can physical activity mitigate the effects of aging in middle-aged women? Circulation 85: 1265-1270, 1992.
18. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436, 2003.
19. Pařízková J: Body Fat and Physical Fitness. Martinus Nijhoff, The Hague. 1977.
20. Pascot A, Lemieux S, Lemieux I, Prud'Homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Despres JP: Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 22: 1471-1478, 1999.
21. Pobišová Z, Zamrazil V, Bláha P, Platilová H, Simečková A, Trunečka E, Vavřejnová V, Reisenauer R: Selected anthropometric findings in women with disorders of glucose tolerance with hypertension. Vnitř Lék 36: 521-525, 1990.
22. Reinecke H, Bogdanski J, Woltering A, Breithardt G, Assmann G, Kerber S, Von Eckardstein A: Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 90: 364-368, 2002.
23. Rossouw JE, Anderson GL, Prentice RL, Lacroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BW, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomised controlled trial. JAMA 288: 321-333, 2002.
24. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE: Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 5: 538-554, 2006.
25. Seed M: The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women. Atherosclerosis Suppl 3: 53-63, 2002.
26. Stevenson JC, Crook D, Godsland IF: Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 98: 83-90, 1993.
27. Vondra K, Stárka L: Obesity viewed by an endocrinologist. In: Aktuální endokrinologie (in Czech), Stárka L et al. (eds), Maxdorf, Prague, 1999, pp 217-242.
28. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H: Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 6: 25-32, 2003.
29. Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H, Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Contraception 2: 83-91, 1998.
30. Živný J: Hormonal replacement therapy. In: Aktuální endokrinologie (in Czech), Stárka L et al. (eds), Maxdorf, Prague, 1999, pp 579-597.